SCHEMBL6949140

SCHEMBL6949140

CC(O)CNc1nc(OCC(F)(F)F)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.39
PIK3CD O00329 1/20 0.38
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 5/20 0.37
MAPT P10636 5/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HTT P42858 3/20 0.37
HPGD P15428 3/20 0.37
TP53 P04637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GBA1 P04062 1/20 0.36
IDH2 P48735 1/20 0.34
GAA P10253 2/20 0.34
HIF1A Q16665 2/20 0.34
POLB P06746 1/20 0.34
LMNA P02545 2/20 0.33
THRB P10828 1/20 0.33
CTSL P07711 3/20 0.33
CTSB P07858 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957130 0.91 IDH2 (0.39) PLK1PIK3CDKDM4EALDH1A1MAPT
SCHEMBL6945704 0.87 GRIN2D (0.41) PLK1PIK3CDKDM4EALDH1A1MAPT
SCHEMBL6955262 0.85 PIK3CD (0.40) PLK1PIK3CDKDM4EALDH1A1MAPT
SCHEMBL6945718 0.85 ALDH1A1 (0.40) PLK1PIK3CDKDM4EALDH1A1MAPT
SCHEMBL6951267 0.83 ALDH1A1 (0.40) PLK1PIK3CDKDM4EALDH1A1MAPT
SCHEMBL6948041 0.83 ABCC1 (0.41) PIK3CDKDM4EALDH1A1MAPTMEN1
SCHEMBL6952840 0.82 PIK3CD (0.38) PIK3CDKDM4EALDH1A1MAPTMEN1
SCHEMBL6956303 0.81 KDM4E (0.41) PIK3CDKDM4EALDH1A1MAPTMEN1
SCHEMBL6955488 0.80 AURKA (0.38) PLK1PIK3CDKDM4EALDH1A1MAPT
SCHEMBL6949377 0.80 MEN1 (0.42) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed